Alvarez RD - Search Results

1

Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines.

Numnum TM, Makhija S, Lu B, Wang M, Rivera A, Stoff-Khalili M, Alvarez RD, Zhu ZB, Curiel DT. Numnum TM, et al. Among authors: alvarez rd. Gynecol Oncol. 2008 Jan;108(1):34-41. doi: 10.1016/j.ygyno.2007.08.096. Epub 2007 Dec 3. Gynecol Oncol. 2008. PMID: 18061250 Free PMC article.

2

Gene therapy for ovarian cancer: progress and potential.

Kirby TO, Curiel DT, Alvarez RD. Kirby TO, et al. Among authors: alvarez rd. Hematol Oncol Clin North Am. 2003 Aug;17(4):1021-50. doi: 10.1016/s0889-8588(03)00055-8. Hematol Oncol Clin North Am. 2003. PMID: 12959190 Review.

3

Transcriptional blocks limit adenoviral replication in primary ovarian tumor.

Preuss MA, Lam JT, Wang M, Leath CA 3rd, Kataram M, Mahasreshti PJ, Alvarez RD, Curiel DT. Preuss MA, et al. Among authors: alvarez rd. Clin Cancer Res. 2004 May 1;10(9):3189-94. doi: 10.1158/1078-0432.ccr-03-0802. Clin Cancer Res. 2004. PMID: 15131060

4

Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma.

Leath CA 3rd, Kataram M, Bhagavatula P, Gopalkrishnan RV, Dent P, Fisher PB, Pereboev A, Carey D, Lebedeva IV, Haisma HJ, Alvarez RD, Curiel DT, Mahasreshti PJ. Leath CA 3rd, et al. Among authors: alvarez rd. Gynecol Oncol. 2004 Aug;94(2):352-62. doi: 10.1016/j.ygyno.2004.04.028. Gynecol Oncol. 2004. PMID: 15297172

5

Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery.

Wang M, Hemminki A, Siegal GP, Barnes MN, Dmitriev I, Krasnykh V, Liu B, Curiel DT, Alvarez RD. Wang M, et al. Among authors: alvarez rd. Gynecol Oncol. 2005 Feb;96(2):341-8. doi: 10.1016/j.ygyno.2004.09.063. Gynecol Oncol. 2005. PMID: 15661219

6

Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo.

Zhu ZB, Makhija SK, Lu B, Wang M, Rivera AA, Kim-Park S, Ulasov IV, Zhou F, Alvarez RD, Siegal GP, Curiel DT. Zhu ZB, et al. Among authors: alvarez rd. Int J Oncol. 2005 Jul;27(1):237-46. Int J Oncol. 2005. PMID: 15942665

7

Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy.

Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, Chada S, Alvarez RD, Haisma HJ, Dent P, Curiel DT. Mahasreshti PJ, et al. Among authors: alvarez rd. Gynecol Oncol. 2006 Mar;100(3):521-32. doi: 10.1016/j.ygyno.2005.08.042. Epub 2005 Oct 12. Gynecol Oncol. 2006. PMID: 16225913

8

Targeted gene therapy for ovarian cancer.

Rocconi RP, Numnum TM, Stoff-Khalili M, Makhija S, Alvarez RD, Curiel DT. Rocconi RP, et al. Among authors: alvarez rd. Curr Gene Ther. 2005 Dec;5(6):643-53. doi: 10.2174/156652305774964668. Curr Gene Ther. 2005. PMID: 16457653 Review.

9

Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy.

Rocconi RP, Numnum MT, Zhu ZB, Lu B, Wang M, Rivera AA, Stoff-Khalili M, Alvarez RD, Curiel DT, Makhija S. Rocconi RP, et al. Among authors: alvarez rd. Gynecol Oncol. 2006 Dec;103(3):985-9. doi: 10.1016/j.ygyno.2006.06.005. Epub 2006 Jul 20. Gynecol Oncol. 2006. PMID: 16857247

10

Gene therapy for ovarian cancer.

Kimball KJ, Numnum TM, Rocconi RP, Alvarez RD. Kimball KJ, et al. Among authors: alvarez rd. Curr Oncol Rep. 2006 Nov;8(6):441-7. doi: 10.1007/s11912-006-0073-x. Curr Oncol Rep. 2006. PMID: 17040622 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters